Literature DB >> 15933848

[How safe is magnetic resonance imaging in patients with contraceptive implants?].

M Mühler1, M Taupitz.   

Abstract

When patients with an implanted contraceptive device undergo MRI, it must be ensured that the examination involves no risk to the patient (MR safety) and that the diagnosis is not affected by artifacts or the function of the device compromised (MR compatibility). Two basic types of intrauterine devices can be distinguished: the metal-containing/metal-free intrauterine device (IUD) and the hormone-containing implant, the fully metal-free intrauterine system (IUS), as well as the ESSURE insert made of stainless steel, which has been approved for use in Europe since February 2001. The metal-containing and metal-free IUDs and ESSURE are MRI compatible up to a magnetic field strength of 1.5 T. They do not interact in any relevant way with the external magnetic or high-frequency field and the temperature increase is within the physiologic range. The implants merely produce a local signal void with a shape that depends on their orientation relative to the magnetic field lines. At 3 T, only the metal-free IUD and the IUS are MRI safe in terms of the material used. In contrast, metal-containing IUDs and the ESSURE have not yet been fully evaluated in the 3 T field, which is why they represent a contraindication to MRI. No data are available on the MRI compatibility at 3 T for any of these devices.

Entities:  

Mesh:

Year:  2006        PMID: 15933848     DOI: 10.1007/s00117-005-1212-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  13 in total

Review 1.  Pre-MRI procedure screening: recommendations and safety considerations for biomedical implants and devices.

Authors:  A M Sawyer-Glover; F G Shellock
Journal:  J Magn Reson Imaging       Date:  2000-07       Impact factor: 4.813

2.  MR Safety and the American College of Radiology White Paper.

Authors:  Frank G Shellock; John V Crues
Journal:  AJR Am J Roentgenol       Date:  2002-06       Impact factor: 3.959

3.  Biomedical implants and devices: assessment of magnetic field interactions with a 3.0-Tesla MR system.

Authors:  Frank G Shellock
Journal:  J Magn Reson Imaging       Date:  2002-12       Impact factor: 4.813

Review 4.  Radiofrequency energy-induced heating during MR procedures: a review.

Authors:  F G Shellock
Journal:  J Magn Reson Imaging       Date:  2000-07       Impact factor: 4.813

5.  Safety of intrauterine contraceptive devices during MR imaging.

Authors:  T Hess; B Stepanow; M V Knopp
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 6.  The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds.

Authors:  J F Schenck
Journal:  Med Phys       Date:  1996-06       Impact factor: 4.071

7.  Lack of interaction between magnetic resonance imaging and the copper-T380A IUD.

Authors:  S A Pasquale; T J Russer; R Foldesy; R S Mezrich
Journal:  Contraception       Date:  1997-03       Impact factor: 3.375

8.  MR imaging artifacts, ferromagnetism, and magnetic torque of intravascular filters, stents, and coils.

Authors:  G P Teitelbaum; W G Bradley; B D Klein
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

9.  New metallic implant used for permanent contraception in women: evaluation of MR safety.

Authors:  Frank G Shellock
Journal:  AJR Am J Roentgenol       Date:  2002-06       Impact factor: 3.959

10.  Intrauterine contraceptive devices: MR imaging.

Authors:  A S Mark; H Hricak
Journal:  Radiology       Date:  1987-02       Impact factor: 11.105

View more
  2 in total

1.  Hysterosalpingogram: an essential examination following Essure hysteroscopic sterilisation.

Authors:  V Shah; N Panay; R Williamson; A Hemingway
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

2.  Magnetic field interactions of copper-containing intrauterine devices in 3.0-Tesla magnetic resonance imaging: in vivo study.

Authors:  Vanessa Berger-Kulemann; Henrik Einspieler; Nilouparak Hachemian; Daniela Prayer; Siegfried Trattnig; Michael Weber; Ahmed Ba-Ssalamah
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.